← Every company
Amgen Inc Lobbying
What Amgen Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
AMGN on carbonthat →Disclosed spend
$3.8M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesCopyright/Patent/TrademarkPharmacyMedicare/MedicaidBudget/AppropriationsTaxation/Internal Revenue Code
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | AMGEN, INC.Health IssuesMedicare/Medicaid | $2.6M |
| 20261st Quarter (Jan 1 - Mar 31) | FORBES-TATEMedicare/MedicaidMedical/Disease Research/Clinical Labs | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPMedicare/MedicaidHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacyCopyright/Patent/Trademark | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPMedicare/MedicaidHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | S-3 GROUPHealth IssuesBudget/Appropriations | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MILLER STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL 6 ADVISORS | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | THE MCMANUS GROUPMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL TAX PARTNERS, LLPTaxation/Internal Revenue Code | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL COUNSEL LLCMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | AKIN GUMP STRAUSS HAUER & FELDTaxation/Internal Revenue Code | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | ACG ADVOCACYCopyright/Patent/Trademark | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | ALPINE GROUP PARTNERS, LLC.Medicare/MedicaidTaxation/Internal Revenue Code | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | OGRMedicare/MedicaidTaxation/Internal Revenue Code | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | EMPIRE CONSULTING GROUPHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | BGR GOVERNMENT AFFAIRSHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | HILLNORTH LLCHealth Issues | $37.5K |
| 20261st Quarter (Jan 1 - Mar 31) | SIGHTLINE ADVOCACY, LLCHealth Issues | $20K |
| 20261st Quarter (Jan 1 - Mar 31) | PANNONE LOPES DEVEREAUX & O'GARA LLCPharmacy | $9K |
| 20261st Quarter (Jan 1 - Mar 31) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health Issues | $7.5K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK HEALTH STRATEGIES, INC. | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on AMGN
Company overviewEverything on AMGN in one place, with the price.SEC filingsWhat AMGN's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat AMGN's own officers and directors buy and sell.Executive payWhat AMGN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in AMGN.Funds holding itWhich funds and ETFs hold AMGN, and how big a bet.Who lobbies for itThe lobbyists on AMGN's account, and who they worked for.Federal contractsWhat federal agencies pay AMGN.PatentsWhat AMGN is filing at the patent office.